CORIN JAYNES: Open Payments
NPI 1619217791 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,149 in 176 payments from 50 companies in 2025. Trend: 2023 $2,921 · 2024 $3,909 · 2025 $5,149
Food & beverage: $3,809Long term medical supply or device loan: $1,180Education: $175
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 25 | $1,472 |
| Merck Sharp & Dohme LLC | 15 | $349 |
| E.R. Squibb & Sons, L.L.C. | 12 | $246 |
| SEAGEN INC. | 2 | $175 |
| PFIZER INC. | 8 | $171 |
| GlaxoSmithKline, LLC. | 8 | $150 |
| Kite Pharma, Inc. | 1 | $144 |
| ABBVIE INC. | 7 | $144 |
| Celgene Corporation | 7 | $139 |
| SOBI, INC | 6 | $130 |
Products named: KISQALI, KEYTRUDA, OPDIVO, Yescarta, Vonjo, OPDUALAG, OJJAARA, VERZENIO.
Industry payments across SC — which companies pay providers there.
